Literature DB >> 7927537

Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene.

C A Abbott1, E Baker, G R Sutherland, G W McCaughan.   

Abstract

CD26 is a lymphocyte cell surface antigen which is increased during T-cell activation and is also expressed in other tissues. It is an atypical serine protease belonging to the prolyl oligopeptidase family. CD26 has been implicated in a variety of biological functions including T-cell activation, cell-to-cell adhesion, and recently in HIV infection. This paper describes, through the isolation and partial sequencing of eight human CD26 genomic clones, the first information on the genomic organization of the prolyl oligopeptidase family. We have established that the human CD26 gene spans approximately 70 kilobases (kb) and contains 26 exons, ranging in size from 45 base pairs (bp) to 1.4 kb. The nucleotides that encode the serine recognition site (G-W-S-Y-G) are split between two exons. This clearly distinguishes the genomic organization of the prolyl oligopeptidase family from that of the classical serine protease family. The 5' flanking domain of the CD26 gene contains neither a TATA box nor a CAAT box, but a 300 bp region extremely rich in C and G (72%) contains potential binding sites for several transcriptional factors. The human CD26 gene encodes two messages sized at about 4.2 and 2.8 kb. These are both expressed at high levels in the placenta and kidney and at moderate levels in the lung and liver. Only the 4.2 kb mRNA was expressed at low levels in skeletal muscle, heart, brain, and pancreas. Fluorescence in situ hybridization on metaphase chromosome spreads located the human CD26 gene to the long arm of chromosome 2(2q24.3).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927537     DOI: 10.1007/bf01246674

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  43 in total

1.  The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta.

Authors:  I Nausch; R Mentlein; E Heymann
Journal:  Biol Chem Hoppe Seyler       Date:  1990-11

2.  Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence.

Authors:  G W McCaughan; J E Wickson; P F Creswick; M D Gorrell
Journal:  Hepatology       Date:  1990-04       Impact factor: 17.425

3.  The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G + C-rich housekeeping promoter.

Authors:  T C Meeker; J Loeb; M Ayres; W Sellers
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.

Authors:  G R Flentke; E Munoz; B T Huber; A G Plaut; C A Kettner; W W Bachovchin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

5.  Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.

Authors:  D A Fox; R E Hussey; K A Fitzgerald; O Acuto; C Poole; L Palley; J F Daley; S F Schlossman; E L Reinherz
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

6.  Molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface.

Authors:  Y Misumi; Y Hayashi; F Arakawa; Y Ikehara
Journal:  Biochim Biophys Acta       Date:  1992-07-15

7.  Identification of the active site residues in dipeptidyl peptidase IV by affinity labeling and site-directed mutagenesis.

Authors:  S Ogata; Y Misumi; E Tsuji; N Takami; K Oda; Y Ikehara
Journal:  Biochemistry       Date:  1992-03-10       Impact factor: 3.162

Review 8.  CD26: a surface protease involved in T-cell activation.

Authors:  B Fleischer
Journal:  Immunol Today       Date:  1994-04

9.  Proteins of the kidney microvillar membrane. Reconstitution of endopeptidase in liposomes shows that it is a short-stalked protein.

Authors:  A J Kenny; I S Fulcher; K A McGill; D Kershaw
Journal:  Biochem J       Date:  1983-06-01       Impact factor: 3.857

10.  Isolation of a cDNA probe for the human intestinal dipeptidylpeptidase IV and assignment of the gene locus DPP4 to chromosome 2.

Authors:  D Darmoul; M Lacasa; I Chantret; D M Swallow; G Trugnan
Journal:  Ann Hum Genet       Date:  1990-07       Impact factor: 1.670

View more
  44 in total

Review 1.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

Review 2.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

3.  Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.

Authors:  P Ruiz; N Zacharievich; M Shenkin
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

Review 4.  Extracellular signaling in Dictyostelium.

Authors:  Kristen M Consalvo; Ramesh Rijal; Yu Tang; Sara A Kirolos; Morgan R Smith; Richard H Gomer
Journal:  Int J Dev Biol       Date:  2019       Impact factor: 2.203

5.  CD26 Identifies a Subpopulation of Fibroblasts that Produce the Majority of Collagen during Wound Healing in Human Skin.

Authors:  Christal A Worthen; Yilei Cui; Jeffrey S Orringer; Timothy M Johnson; John J Voorhees; Gary J Fisher
Journal:  J Invest Dermatol       Date:  2020-05-11       Impact factor: 8.551

6.  GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors:  Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

7.  Adenosine neuromodulation and traumatic brain injury.

Authors:  T A Lusardi
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

8.  Cluster analysis and phylogenetic relationship in biomarker identification of type 2 diabetes and nephropathy.

Authors:  Satya Vani Guttula; Allam Appa Rao; G R Sridhar; M S Chakravarthy; Kunjum Nageshwararo; Paturi V Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

9.  Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.

Authors:  James Brian Byrd; Karine Touzin; Saba Sile; James V Gainer; Chang Yu; John Nadeau; Albert Adam; Nancy J Brown
Journal:  Hypertension       Date:  2007-11-19       Impact factor: 10.190

Review 10.  Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospects.

Authors:  Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2016-08-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.